1. Home
  2. FAMI vs CTXR Comparison

FAMI vs CTXR Comparison

Compare FAMI & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Farmmi Inc.

FAMI

Farmmi Inc.

N/A

Current Price

$1.25

Market Cap

17.0M

ML Signal

N/A

Logo Citius Pharmaceuticals Inc.

CTXR

Citius Pharmaceuticals Inc.

HOLD

Current Price

$0.70

Market Cap

16.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FAMI
CTXR
Founded
2015
2007
Country
China
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.0M
16.8M
IPO Year
2017
2010

Fundamental Metrics

Financial Performance
Metric
FAMI
CTXR
Price
$1.25
$0.70
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$6.00
AVG Volume (30 Days)
10.5K
625.2K
Earning Date
08-04-2025
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
43.38
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$147.57
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.11
$0.63
52 Week High
$2.22
$2.38

Technical Indicators

Market Signals
Indicator
FAMI
CTXR
Relative Strength Index (RSI) 45.50 41.06
Support Level $1.23 $0.70
Resistance Level $1.39 $0.99
Average True Range (ATR) 0.06 0.08
MACD -0.00 -0.02
Stochastic Oscillator 8.22 6.57

Price Performance

Historical Comparison
FAMI
CTXR

About FAMI Farmmi Inc.

Farmmi Inc is an investment holding company. Through its subsidiaries, it acts as a supplier of agricultural products. It is an agricultural technology enterprise focused on its supply chain platform by promoting edible mushroom products and agriculture technology. Its product offerings include tapioca, corn, red dates, shiitake mushrooms, mu er fungus, other edible fungi, and other agricultural products. Geographically, the company's products are sold in China, Southeast Asia, Japan, North America, Europe and the Middle East under the Forasen and Farmmi brands.

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, with a focus on oncology, anti-infectives in adjunct cancer care and distinct prescription products. It aims to provide therapeutic products that address unmet medical needs yet have a lower development risk than is usually associated with new chemical entities. The company's flagship product candidate is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein. It operates through a single operating and reportable segment which is focused on developing and commercializing pioneering targeted oncology therapies.

Share on Social Networks: